GEN Exclusives

More »

GEN News Highlights

More »
Jul 22, 2009

Polish University to Use Cellectricon’s Transfection System

  • The University of Lodz, Poland, will invest in Cellectricon’s Cellaxess®HT. The university plans to use the product for its research program focusing on cell biology and molecular genetics of clinically relevant genes related to cancer treatment.

    Cellaxess®HT is a fully automated workstation for high-throughput transfection. The system enables reagent-free delivery of siRNA and cDNA to a range of primary cells and cell lines.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »